Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain

CompletedOBSERVATIONAL

Enrollment

2,251

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

May 31, 2015

Conditions

Atrial Fibrillation

Interventions

DRUG

Rivaroxaban (Xarelto, BAY59-7939)

Patients treated by Physicians under approved local prescriptions

Trial Locations (1)

Many Locations